Fernando P.
- Country
- France
- Department
- Neurology
Research Overview
- Tenecteplase plus Thrombectomy versus Thrombectomy Alone in Patients with Large Core Ischemic Stroke: A Multicentre Randomized Controlled Trial
- Efficacy of Apixaban Versus Standard Care in Patients with Intracerebral Hemorrhage: A Randomized Controlled Trial
- Evaluation of Tenecteplase Versus Alteplase in Acute Ischaemic Stroke Due to Basilar Artery Occlusion: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 36 of 120 partner sites.
Specializations
Stroke Management
Specialized in addressing acute ischemic stroke conditions, particularly focusing on basilar artery occlusion treatment strategies. Investigates innovative approaches in thrombolytic therapy for improving patient outcomes.
- Basilar Artery Occlusion Treatment
- Acute Stroke Interventions
- Thrombolytic Therapy Optimization
Explores extended treatment windows for stroke intervention using advanced therapeutic agents.
Cerebrovascular Disorders
Focuses on complex cerebrovascular conditions including giant cell arteritis and intracerebral hemorrhage. Investigates novel therapeutic approaches for managing cerebrovascular complications.
- Giant Cell Arteritis Treatment
- Hemorrhagic Stroke Management
- Cerebrovascular Disease Prevention
Explores innovative therapeutic agents and strategies for cerebrovascular disorder management.
Vascular Medicine
Specializes in comprehensive treatment of cardiovascular and cerebrovascular conditions, including research on atherosclerosis and its complications. Studies preventive approaches for recurrent vascular events.
- Vascular Disease Prevention
- Anticoagulation Management
- Combined Cardiovascular Therapies
Investigates long-term therapeutic strategies for vascular disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.